Specialty Pharmacy

Camber Pharmaceuticals presents Econdisc Contracting Solutions with Customer of the Year award at the 2014 NACDS Total Store Show.

Efforts to contain the virus increase as death toll continues to rise.

Researchers find 23 new prostate cancer risk sites on the genome.

Paper also offers insight from specific case studies into the ACO-PAC Engagement Spectrum.

Much higher rate of patients in real world discontinuing high priced treatment than during clinical studies.

Disease modifying therapy maintains effects of interferon in the body for a longer duration.

Study finds tolerance varies between individuals determined by their genes.

The severe respiratory virus that is hospitalizing children across the United States has now been confirmed in 17 states.

Michael Nameth, RPh, MBA, chief executive officer of Aureus Health Services, discusses information people entering the field of specialty pharmacy need to know.

Using a less market-oriented payment scheme could reduce high hospital administrative costs.

Baldness on front and crown of head linked to increased chance of developing aggressive prostate cancer.

The FDA has granted approval for the use of hemophilia B treatment Rixubis in pediatric patients.

The respiratory virus that hospitalized hundreds of children in the Midwest and the South has now reached the Northeast.

Researchers found a single receptor that appears to aggravate RA symptoms.

Current transmission rates from primary cases to secondary cases could cause Ebola epidemic to explode.

In several countries, increases in the incidence of inflammatory bowel disease have been observed closely following regulatory approval of sucralose.

Infliximab shows efficacy in IBD patients who suspend therapy.

Biosimilars are an estimated 30% cheaper than branded biologics

For the first time, an oral therapy has been proven to reduce the risk of developing clinically definite multiple sclerosis in patients with a clinically isolated syndrome.

Assessing a patient's sense of balance and hearing ability may be an aid in diagnosing psoriatic arthritis.

Combined specialty pharmacy organization poised to advance the field amid changing health care landscape.

Organization warns disease is spreading faster than it can be contained.

A prognostic disease marker that often occurs in patients with triple-negative breast cancer may lead to development of a medication to close a therapeutic gap in targeted cancer treatment.

Countries at highest risk for Ebola transmission identified through animal migration patterns.

Commentary stresses importance of safe removal of protective gear among those caring for infected patients.

Data indicates that a simeprevir-based therapy is efficacious in patients with HIV-1/HCV genotype 1 coinfection.

Bill Barre, RPh, vice president of business development at MedImpact Healthcare Systems, how specialty pharmacies can meet the demands of consumerism in the new era of prescription fulfillment.